ReviewElectrolyte & blood pressure : E & BP2026
Glomerulo-Tubular Crosstalk in Diabetic Kidney Disease: From Pathophysiology to Novel Therapeutics.
Review in Electrolyte & blood pressure : E & BP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic kidney disease (DKD) remains the leading cause of chronic kidney disease and kidney failure worldwide despite advances in glycemic and blood pressure control. Although DKD has traditionally been viewed as a primarily glomerular disorder, growing evidence suggests that its progression is shaped by complex communication between the glomerulus and the tubulointerstitium. Under diabetic conditions characterized by persistent hyperglycemia, oxidative stress, and metabolic imbalance, signaling networks among glomerular endothelial cells, podocytes, and mesangial cells become disrupted. Glomerular injury may generate downstream signals, including proteinuria and loss of protective mediators, that impose inflammatory and metabolic stress on proximal tubular epithelial cells and may activate profibrotic pathways. Conversely, injured tubular cells release cytokines, chemokines, and extracellular vesicles that may influence glomerular cells and further contribute to structural damage. In addition, metabolic disturbances within tubular cells, such as lipid accumulation, mitochondrial dysfunction, and cellular stress responses, may promote tubulointerstitial fibrosis. Viewing DKD as a disorder of disrupted glomerulo-tubular communication provides an integrated framework linking pathophysiological mechanisms with emerging therapeutic strategies aimed at slowing disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.